When the guard’s parents learned of their son’s death, they were outraged. They were even more furious to learn that they could not file criminal charges against InGen under U.S. law: though InGen was incorporated in the U.S., the facility at which their son was injured was located in another country, outside U.S. criminal jurisdiction. The guard’s parents were able to file a civil suit against InGen, seeking damages for their son’s death.
This legal suit concerned some of InGen’s investors, who became worried about the safety of the Costa Rican genetic research facility. To convince investors that the facility was safe, InGen brought in three university researchers to tour the transgenic research facility.